|
注册号: Registration number: |
ChiCTR2100051566 |
|
最近更新日期: Date of Last Refreshed on: |
2022-06-14 06:12:15 |
|
注册时间: Date of Registration: |
2021-09-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
rTMS干预脑卒中患者下肢运动功能障碍的疗效及脑重塑机制 |
|
Public title: |
The effect of rTMS intervention on lower limb motor dysfunction in stroke patients and the mechanism of brain remodeling |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
rTMS干预脑卒中患者下肢运动功能障碍的疗效及脑重塑机制 |
|
Scientific title: |
The effect of rTMS intervention on lower limb motor dysfunction in stroke patients and the mechanism of brain remodeling |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨金宇 |
研究负责人: |
苏彬 |
|
Applicant: |
Yang Jinyu |
Study leader: |
Su Bin |
|
申请注册联系人电话: Applicant telephone: |
+86 15633031386 |
研究负责人电话:
Study leader's |
+86 15306175095 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yangjinyu2423@163.com |
研究负责人电子邮件: Study leader's E-mail: |
13951585359@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省无锡市滨湖区钱荣路158号 |
研究负责人通讯地址: |
江苏省无锡市滨湖区钱荣路158号 |
|
Applicant address: |
156 Qianrong Road, Binhu District, Wuxi, Jiangsu |
Study leader's address: |
156 Qianrong Road, Binhu District, Wuxi, Jiangsu |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
无锡市同仁康复医院 |
||
|
Applicant's institution: |
Wuxi Tongren Rehabilitation Hospital |
||
|
研究负责人所在单位: |
无锡市同仁康复医院 |
||
|
Affiliation of the Leader: |
Wuxi Tongren Rehabilitation Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WXMHCIRB2020LLky013 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
无锡市精神卫生中心伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Wuxi Mental Health Center |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-07-29 00:00:00 | ||
|
伦理委员会联系人: |
惠存竹 |
||
|
Contact Name of the ethic committee: |
Hui Cunzhu |
||
|
伦理委员会联系地址: |
江苏省无锡市滨湖区钱荣路156号 |
||
|
Contact Address of the ethic committee: |
156 Qianrong Road, Binhu District, Wuxi, Jiangsu |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
无锡市同仁康复医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Wuxi Tongren Rehabilitation Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省无锡市滨湖区钱荣路158号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
156 Qianrong Road, Binhu District, Wuxi, Jiangsu |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无锡“双百”人才计划 |
||||||||||||||||||||||
|
Source(s) of funding: |
Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee |
||||||||||||||||||||||
|
研究疾病: |
脑卒中 |
||||||||||||||||||||||
|
Target disease: |
stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究通过静息态fMRI揭示脑卒中后的下肢运动功能障碍的特征,明确rTMS可改善患者的下肢运动功能,另外将大脑行为与下肢的感觉运动功能恢复联系起来,探究rTMS促进脑卒中下肢功能恢复的神经重塑机制。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study uses resting state fMRI to reveal the characteristics of lower extremity motor dysfunction after stroke, and confirms that rTMS can improve the patient's lower extremity motor function. In addition, The brain behavior and the sensorimotor function recovery of the lower extremities are linked to explore the neural remodeling mechanism of rTMS to promote the recovery of the lower extremity function after stroke. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.有TMS及fMRI的相关禁忌症者(心脏起搏器,颅内植入物,植入药物泵或妊娠等); |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Those with contraindications to TMS and fMRI (pacemaker, intracranial implant, implanted drug pump or pregnancy, etc.); |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-09-26 00:00:00至 To 2022-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-09-26 00:00:00 至 To 2022-03-26 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
使用spss软件进行随机分组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
SPSS software was used for random grouping |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
Not stated |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
原始数据将于实验完成后6个月内公开,读者可在合理范围内向研究负责主要人员索取原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The original data will be made public within 6 months of the completion of the trial and may be obtained by readers from the principal investigators within reasonable limits. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |